Physician profile
Kirk W Walker
NPI 1922076546
$2,670.87
in general payments reported to CMS, 2019-2025
17 companies · $436 in 2025
The $436 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $354 · 2021: $61.03 · 2022: $541 · 2023: $403 · 2024: $128 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $716.88 | 2019-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $333.42 | 2023-2025 | |
| Abbott Laboratories | $298.37 | 2019-2024 | Gallant |
| Boston Scientific Corporation | $219.78 | 2019-2023 | Watchman |
| Medtronic Vascular, INC. | $207.62 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $131.19 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $120.00 | 2019 | |
| Pfizer INC. | $106.82 | 2019-2020 | |
| Atricure, INC. | $104.27 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Esperion Therapeutics, INC. | $98.38 | 2025 | Nexletol |
| Abiomed | $79.85 | 2019 | |
| Irhythm Technologies, INC. | $73.59 | 2019-2023 | Zio Xt Patch |
| Regeneron Pharmaceuticals, INC. | $61.03 | 2021 | |
| Amarin Pharma, INC. | $41.66 | 2020 | |
| Impulse Dynamics (USA) INC. | $30.69 | 2024 | Optimizer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.23 | 2019 | |
| Novo Nordisk INC | $23.09 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.